home / stock / anip / anip news


ANIP News and Press, ANI Pharmaceuticals Inc. From 05/10/22

Stock Information

Company Name: ANI Pharmaceuticals Inc.
Stock Symbol: ANIP
Market: NASDAQ
Website: anipharmaceuticals.com

Menu

ANIP ANIP Quote ANIP Short ANIP News ANIP Articles ANIP Message Board
Get ANIP Alerts

News, Short Squeeze, Breakout and More Instantly...

ANIP - ANI Pharmaceuticals, Inc. (ANIP) CEO Nikhil Lalwani on Q1 2022 Results - Earnings Call Transcript

ANI Pharmaceuticals, Inc. (ANIP) Q1 2022 Earnings Conference Call May 10, 2022 8:30 a.m. ET Company Participants Lisa Wilson - Investor Relations Nikhil Lalwani - President and Chief Executive Officer Steve Carey - Chief Financial Officer Chris Mutz - Head of Rare Disease Conference Call Part...

ANIP - ANI Pharmaceuticals Non-GAAP EPS of -$0.12 misses by $0.21, revenue of $64.48M misses by $0.55M

ANI Pharmaceuticals press release (NASDAQ:ANIP): Q1 Non-GAAP EPS of -$0.12 misses by $0.21. Revenue of $64.48M (+18.3% Y/Y) misses by $0.55M. Provides Purified Cortrophin® Gel 2022 Net Revenue guidance of $35 million to $40 million, Total Company Net Revenue guidance of $295 million...

ANIP - ANI Pharmaceuticals Reports First Quarter 2022 Results; Provides Purified Cortrophin® Gel Net Revenue Guidance and Full-Year 2022 Total Company Net Revenue Guidance of $295 Million to $315 Million

-- First quarter net revenues of $64.5 million, net loss of $(20.1) million and diluted GAAP loss per share of $(1.27) -- -- First quarter adjusted non-GAAP EBITDA of $4.3 million and adjusted non-GAAP diluted loss per share of $(0.12) -- -- Provides Purified Cortrophi...

ANIP - ANI Pharmaceuticals Q1 2022 Earnings Preview

ANI Pharmaceuticals (NASDAQ:ANIP) is scheduled to announce Q1 earnings results on Tuesday, May 10th, before market open. The consensus EPS Estimate is $0.09 (-91.3% Y/Y) and the consensus Revenue Estimate is $65.03M (+19.3% Y/Y). Over the last 2 years, ANIP has beaten EPS estimates 63% of the...

ANIP - ANI Pharmaceuticals to Discuss First Quarter 2022 Financial Results on May 10, 2022

ANI Pharmaceuticals, Inc. (“ANI” or the “Company”) (NASDAQ: ANIP) today announced that the Company will release its first quarter 2022 financial results on Tuesday, May 10, 2022. Nikhil Lalwani, President and Chief Executive Officer, and Stephen P. Carey,...

ANIP - ANI Pharmaceuticals Announces the Launch of Misoprostol Tablets

ANI Pharmaceuticals, Inc. (“ANI” or the “Company”) (Nasdaq: ANIP) today announced the launch of Misoprostol Tablets, 100 mcg and 200 mcg. ANI’s Misoprostol Tablets are the generic version of the Reference Listed Drug (RLD) Cytotec ® . The ...

ANIP - Shares of ANI Pharmaceuticals Inc. (ANIP) Rise to a New 52-Week High

Shares of ANI Pharmaceuticals Inc. (NASDAQ:ANIP) traded today at $86.44, eclipsing its 52-week high. Approximately 12.2 million shares have changed hands today, as compared to an average 30-day volume of 187,000 shares. ANI Pharmaceuticals Inc. (NASDAQ:ANIP) is currently priced 2.0% abov...

ANIP - Shares of ANI Pharmaceuticals Inc. (ANIP) Exceed 52-Week High

Shares of ANI Pharmaceuticals Inc. (NASDAQ:ANIP) traded at a new 52-week high today of $86.44. This new high was reached on above average trading volume as 12.2 million shares traded hands, while the average 30-day volume is approximately 188,000 shares. Based on a current price of $28.9...

ANIP - Insider Weekends: Return Of The Meme Stocks - GameStop And AMC Entertainment

“Meme stocks” GameStop and AMC Entertainment saw their stocks surge last week. GameStop registered a gain of over 67% for the week. Billionaire founder of online pet retailer Chewy, Ryan Cohen, Alain Attal, a Chewy executive, and Lawrence Cheng, a Managing Partner of...

ANIP - ANI Pharmaceuticals Appoints Experienced Commercial Leader, Renee P. Tannenbaum, Pharm.D., MBA, to Board of Directors

-- Dr. Tannenbaum’s successful track record in driving commercial excellence to contribute as Company executes Purified Cortrophin Gel TM launch -- ANI Pharmaceuticals, Inc. (Nasdaq: ANIP) (ANI or the Company) today announced the addition of Renee P. Tannenbaum, P...

Previous 10 Next 10